Pareto analyst Filip Wiberg downgraded Xvivo Perfusion (XVIPF) to Hold from Buy with a price target of SEK 500, down from SEK 560. The firm says it is time for the shares to “take a breather.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue